表紙
市場調査レポート

中国の体外診断 (IVD) 市場の将来展望:臨床化学、遺伝子検査、血液検査、組織学・細胞学、免疫化学、感染症診断、微生物培養

China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

発行 GlobalData 商品コード 349846
出版日 ページ情報 英文 288 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
中国の体外診断 (IVD) 市場の将来展望:臨床化学、遺伝子検査、血液検査、組織学・細胞学、免疫化学、感染症診断、微生物培養 China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
出版日: 2015年10月12日 ページ情報: 英文 288 Pages
概要

当レポートでは、中国国内における体外診断 (IVD) 用医薬品の市場について分析し、全体的な市場動向の見通し (金額ベース、過去・今後8年間分) や、企業別・流通チャネル別の市場シェア、主要セグメント別 (臨床化学、遺伝子検査、血液検査、組織学・細胞学、免疫化学、感染症診断、微生物培養) の詳細動向、主なパイプライン製品と治験の進行状況、主要企業のプロファイル、昨今の市場の主な動きなどについて調査しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • 体外診断 (IVD) 市場の内訳
  • 分析対象市場の定義

第3章 中国の体外診断 (IVD) 市場

  • 市場収益額の動向見通し (通算15年間分)
  • 市場収益額の構成
  • 市場収益額の内訳:カテゴリー別
  • カテゴリー別の市場収益額の比較 (通算15年間分)
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
  • 企業別の市場シェア

第4章 中国の臨床化学市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
    • 臨床化学分析装置の市場動向 (過去・今後8年間分)
    • 治療薬モニタリングの市場動向 (過去・今後8年間分)
    • 尿検査の市場動向 (過去・今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第5章 中国の遺伝子検査市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第6章 中国の血液検査市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
    • 血液細胞カウンターの市場動向 (過去・今後8年間分)
    • 迅速/POC (ポイントオブケア) 血液検査の市場動向 (過去・今後8年間分)
    • 血液検査用試薬の市場動向 (過去・今後8年間分)
    • 止血検査の市場動向 (過去・今後8年間分)
    • 免疫血液検査の市場動向 (過去・今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第7章 中国の組織学・細胞学市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第8章 中国の免疫化学市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
    • 貧血症検査の市場動向 (過去・今後8年間分)
    • 疾患特異的免疫化学療法の市場動向 (過去・今後8年間分)
    • 内分泌検査の市場動向 (過去・今後8年間分)
    • IgEアレルギー血液検査の市場動向 (過去・今後8年間分)
    • 免疫化学分析装置の市場動向 (過去・今後8年間分)
    • 免疫化学用迅速/POC (ポイントオブケア) 検査の市場動向 (過去・今後8年間分)
    • ビタミン検査の市場動向 (過去・今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第9章 中国の感染症診断薬市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
    • 感染症診断用迅速/POC (ポイントオブケア) 検査の市場動向 (過去・今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第10章 中国の微生物培養市場

  • 市場収益額の構成
  • 市場収益額の内訳:部門別
  • 市場収益額の実績値 (過去8年間分)
  • 市場収益額の予測値 (今後8年間分)
    • 微生物分析装置の市場動向 (過去・今後8年間分)
  • 流通チャネル別の市場シェア
  • 企業別の市場シェア

第11章 主要企業のプロファイル:中国の体外診断市場

  • Siemens Healthcare
  • Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • シスメックス
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Mindray Medical International Limited
  • bioMerieux S.A.
  • Thermo Fisher Scientific Inc.
  • Ortho-Clinical Diagnostics Inc.
  • 日本光電工業
  • Alere Inc.
  • デンカ生研

第12章 体外診断市場のパイプライン製品

第13章 資本取引環境

  • 企業買収 (全4件)
  • 社債発行 (1件)
  • 株式発行 (全6件)
  • 事業提携 (全39件)
  • プライベートエクイティ (未公開株取引) (1件)
  • ベンチャー融資 (1件)

第14章 近年の動向

  • 企業からの発表 (コーポレート・コミュニケーション) (全8件)
  • 決算発表 (全15件)
  • 政府・公共機関関連の動き (1件)
  • 法令・規制関連の動き (1件)
  • その他の主な動き (全5件)
  • 製品ニュース (全2件)
  • 戦略・事業計画 (全8件)

第15章 付録

図表一覧

目次
Product Code: GDMEMC0099DB

GlobalData's new report, "China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the China In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for In Vitro Diagnostics market.
  • Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. In Vitro Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. In Vitro Diagnostics Market, China

  • 3.1. In Vitro Diagnostics Market, China, Revenue ($m), 2007-2021
  • 3.2. In Vitro Diagnostics Market, China, Revenue Mix ($m), 2014
  • 3.3. In Vitro Diagnostics Market, China, Category Contribution by Revenue ($m), 2014
  • 3.4. In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), 2007-2021
  • 3.5. In Vitro Diagnostics Market, China, Revenue ($m), 2007-2014
  • 3.6. In Vitro Diagnostics Market, China, Revenue ($m), 2014-2021
  • 3.7. In Vitro Diagnostics Market, China, Company Share by Revenue ($m), 2014

4. Clinical Chemistry Market, China

  • 4.1. Clinical Chemistry Market, China, Revenue Mix ($m), 2014
  • 4.2. Clinical Chemistry Market, China, Segment Contribution (%), 2014
  • 4.3. Clinical Chemistry Market, China, Revenue ($m), 2007-2014
  • 4.4. Clinical Chemistry Market, China, Revenue ($m), 2014-2021
    • 4.4.1. Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014
    • 4.4.2. Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2007-2014
    • 4.4.3. Urine Analysis Market, China, Revenue ($m), by Segment, 2007-2014
    • 4.4.4. Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021
    • 4.4.5. Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2014-2021
    • 4.4.6. Urine Analysis Market, China, Revenue ($m), by Segment, 2014-2021
  • 4.5. Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 4.6. Clinical Chemistry Market, China, Company Share by Revenue ($m), 2014

5. Genetic Testing Market, China

  • 5.1. Genetic Testing Market, China, Revenue Mix ($m), 2014
  • 5.2. Genetic Testing Market, China, Segment Contribution (%), 2014
  • 5.3. Genetic Testing Market, China, Revenue ($m), 2007-2014
  • 5.4. Genetic Testing Market, China, Revenue ($m), 2014-2021
  • 5.5. Genetic Testing Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 5.6. Genetic Testing Market, China, Company Share by Revenue ($m), 2014

6. Haematology Market, China

  • 6.1. Haematology Market, China, Revenue Mix ($m), 2014
  • 6.2. Haematology Market, China, Segment Contribution (%), 2014
  • 6.3. Haematology Market, China, Revenue ($m), 2007-2014
  • 6.4. Haematology Market, China, Revenue ($m), 2014-2021
    • 6.4.1. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014
    • 6.4.2. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 6.4.3. Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014
    • 6.4.4. Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014
    • 6.4.5. Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014
    • 6.4.6. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021
    • 6.4.7. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
    • 6.4.8. Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021
    • 6.4.9. Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021
    • 6.4.10. Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021
  • 6.5. Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 6.6. Haematology Market, China, Company Share by Revenue ($m), 2014

7. Histology And Cytology Market, China

  • 7.1. Histology And Cytology Market, China, Revenue Mix ($m), 2014
  • 7.2. Histology And Cytology Market, China, Segment Contribution (%), 2014
  • 7.3. Histology And Cytology Market, China, Revenue ($m), 2007-2014
  • 7.4. Histology And Cytology Market, China, Revenue ($m), 2014-2021
  • 7.5. Histology And Cytology Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 7.6. Histology And Cytology Market, China, Company Share by Revenue ($m), 2014

8. Immuno Chemistry Market, China

  • 8.1. Immuno Chemistry Market, China, Revenue Mix ($m), 2014
  • 8.2. Immuno Chemistry Market, China, Segment Contribution (%), 2014
  • 8.3. Immuno Chemistry Market, China, Revenue ($m), 2007-2014
  • 8.4. Immuno Chemistry Market, China, Revenue ($m), 2014-2021
    • 8.4.1. Anemia Tests Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.2. Disease Specific Immunochemistry Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.3. Endocrinology Tests Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.4. IgE Allergy Blood Tests Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.5. Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.6. Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.7. Vitamins Tests Market, China, Revenue ($m), by Segment, 2007-2014
    • 8.4.8. Anemia Tests Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.9. Disease Specific Immunochemistry Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.10. Endocrinology Tests Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.11. IgE Allergy Blood Tests Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.12. Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.13. Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
    • 8.4.14. Vitamins Tests Market, China, Revenue ($m), by Segment, 2014-2021
  • 8.5. Immuno Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 8.6. Immuno Chemistry Market, China, Company Share by Revenue ($m), 2014

9. Infectious Diagnostics Market, China

  • 9.1. Infectious Diagnostics Market, China, Revenue Mix ($m), 2014
  • 9.2. Infectious Diagnostics Market, China, Segment Contribution (%), 2014
  • 9.3. Infectious Diagnostics Market, China, Revenue ($m), 2007-2014
  • 9.4. Infectious Diagnostics Market, China, Revenue ($m), 2014-2021
    • 9.4.1. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 9.4.2. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
  • 9.5. Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 9.6. Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014

10. Microbiology Culture Market, China

  • 10.1. Microbiology Culture Market, China, Revenue Mix ($m), 2014
  • 10.2. Microbiology Culture Market, China, Segment Contribution (%), 2014
  • 10.3. Microbiology Culture Market, China, Revenue ($m), 2007-2014
  • 10.4. Microbiology Culture Market, China, Revenue ($m), 2014-2021
    • 10.4.1. Microbiology Analyzers Market, China, Revenue ($m), by Segment, 2007-2014
    • 10.4.2. Microbiology Analyzers Market, China, Revenue ($m), by Segment, 2014-2021
  • 10.5. Microbiology Culture Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 10.6. Microbiology Culture Market, China, Company Share by Revenue ($m), 2014

11. Overview of Key Companies in China, In Vitro Diagnostics Market

  • 11.1. Siemens Healthcare
    • 11.1.1. Company Overview
  • 11.2. F. Hoffmann-La Roche Ltd.
    • 11.2.1. Company Overview
  • 11.3. Danaher Corporation
    • 11.3.1. Company Overview
  • 11.4. Abbott Laboratories
    • 11.4.1. Company Overview
  • 11.5. Sysmex Corporation
    • 11.5.1. Company Overview
  • 11.6. Becton, Dickinson and Company
    • 11.6.1. Company Overview
  • 11.7. Bio-Rad Laboratories, Inc.
    • 11.7.1. Company Overview
  • 11.8. Mindray Medical International Limited
    • 11.8.1. Company Overview
  • 11.9. bioMerieux S.A.
    • 11.9.1. Company Overview
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1. Company Overview
  • 11.11. Ortho-Clinical Diagnostics Inc.
    • 11.11.1. Company Overview
  • 11.12. Nihon Kohden Corporation
    • 11.12.1. Company Overview
  • 11.13. Alere Inc.
    • 11.13.1. Company Overview
  • 11.14. Denka Seiken Co., Ltd.
    • 11.14.1. Company Overview

12. In Vitro Diagnostics Market Pipeline Products

13. Financial Deals Landscape

  • 13.1. Acquisition
    • 13.1.1. Zhejiang Hisun Pharma to Acquire 33% Stake in Zhejiang-based Medical Apparatus and Instruments Company for USD2.3 Million
    • 13.1.2. Hangzhou Century to Acquire Ewell for USD178 Million
    • 13.1.3. Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million
    • 13.1.4. Beijing Leadman Biochemistry Plans to Acquire Stakes in Shanghai Units of DiaSys Diagnostic Systems for USD55.4 Million
  • 13.2. Debt Offerings
    • 13.2.1. Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes
  • 13.3. Equity Offerings
    • 13.3.1. Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares
    • 13.3.2. Lepu Medical Technology to Raise USD200.8 Million in Private Placement of Shares
    • 13.3.3. Guangzhou Wondfo Biotech Raises USD57.5 Million in IPO
    • 13.3.4. Lepu Medical Amends Terms of Private Placement of Shares for USD208 Million
    • 13.3.5. Beijing Strong Biotech Prices IPO for USD57 Million
    • 13.3.6. Beijing Leadman Biochemistry Plans to Raise USD18.5 Million in Private Placement
  • 13.4. Partnerships
    • 13.4.1. Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept
    • 13.4.2. Seegene Enters into Co-Development Agreement with BD Life Sciences
    • 13.4.3. OriGene Technologies Enters into Licensing Agreement with Diadexus
    • 13.4.4. MdxHealth Enters into Licensing Agreement with Erasmus MC
    • 13.4.5. Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
    • 13.4.6. Sigma-Aldrich Enters into Distribution Agreement with LGC
    • 13.4.7. OvaGene Oncology Enters into Agreement with Etta Healthcare
    • 13.4.8. Shuwen Biotech Enters into Agreement with Jiangsu Hengrui Medicine
    • 13.4.9. InTouch Health Enters into Agreement with iSchemaView
    • 13.4.10. DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
    • 13.4.11. Shanghai Runda to Form Joint Venture with Sinopharm
    • 13.4.12. Illumina Enters into Co-Development Agreement with Annoroad Gene Technology
    • 13.4.13. WuXi AppTec Enters into Agreement with Fudan University
    • 13.4.14. Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
    • 13.4.15. Livzon Pharma to Form Joint Venture with Cynvenio Biosystems
    • 13.4.16. Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests
    • 13.4.17. Shanghai Lidebiotech Enters into Agreement with Clearbridge BioMedics
    • 13.4.18. DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test
    • 13.4.19. IncellDx Enters into Licensing Agreement with Claremont BioSolutions
    • 13.4.20. Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing
    • 13.4.21. AngioDynamics Enters into Licensing Agreement with EmboMedics
    • 13.4.22. Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems
    • 13.4.23. Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology
    • 13.4.24. Biocartis Enters into Licensing and Development Agreement with Microbiome
    • 13.4.25. CBScientific Enters into Distribution Agreement with UTest
    • 13.4.26. GeneThera Enters into Co-Development Agreement with Hudson Robotics
    • 13.4.27. Nanospeed Enters into Distribution Agreement with DiaSys for Test4D
    • 13.4.28. Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
    • 13.4.29. Genomic Vision Extends Agreement with Quest Diagnostics
    • 13.4.30. Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ
    • 13.4.31. Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software
    • 13.4.32. BioMerieux Enters into Licensing Agreement with Astute Medical
    • 13.4.33. MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology
    • 13.4.34. NoemaLife Enters into Distribution Agreement with Horiba Medical
    • 13.4.35. Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management
    • 13.4.36. Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
    • 13.4.37. Enigma Diagnostics Forms Joint Venture with Beijing Leadman Biochemistry
    • 13.4.38. Clinical Genomics Enters into Licensing Agreement with CSIRO
    • 13.4.39. Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical
  • 13.5. Private Equity
    • 13.5.1. Mindray Medical Receives Revised Non-Binding Going Private Proposal from Li Xiting, Xu Hang and Cheng Minghe
  • 13.6. Venture Financing
    • 13.6.1. CANbridge Life Sciences Raises USD10 Million in Series A Venture Financing

14. Recent Developments

  • 14.1. Corporate Communications
    • 14.1.1. Jun 30, 2015: Shuwen Biotech Appoints Recognized Leader in Urologic Pathology to Advisory Board
    • 14.1.2. Jun 15, 2015: OmniVision Launches Ultra-Compact, Cost-Effective CameraChip Sensor for Advanced Medical Imaging
    • 14.1.3. Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality
    • 14.1.4. Jun 04, 2015: World Glaucoma Congress to Feature Symposium on XEN Gel Stent for Minimally Invasive IOP Reduction
    • 14.1.5. Apr 15, 2015: PerkinElmer Launches First Fully Automated Genetic Disorder Screening System in China
    • 14.1.6. Feb 25, 2015: Diagnostic Industry Veteran Gregory C. Critchfield Joins Shuwen Biotech's Advisory Board
    • 14.1.7. Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner
    • 14.1.8. Dec 04, 2014: Neogen names COO
  • 14.2. Financial Announcements
    • 14.2.1. Sep 28, 2015: Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial
    • 14.2.2. Aug 10, 2015: Mindray Announces Second Quarter 2015 Financial Results
    • 14.2.3. Jul 21, 2015: Neogen reports record revenues and earnings
    • 14.2.4. May 11, 2015: Mindray Announces First Quarter 2015 Financial Results
    • 14.2.5. May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium
    • 14.2.6. Apr 20, 2015: Pluristem's Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan
    • 14.2.7. Mar 26, 2015: Neogen reports 13% increase in net income
    • 14.2.8. Mar 09, 2015: Mindray Announces 2014 Fourth Quarter and Full Year Results
    • 14.2.9. Mar 04, 2015: Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep in Greater China
    • 14.2.10. Jan 12, 2015: Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance
    • 14.2.11. Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18
    • 14.2.12. Dec 18, 2014: Neogen reports 26% increase in net income
    • 14.2.13. Nov 03, 2014: Mindray Announces Third Quarter 2014 Financial Results
    • 14.2.14. Oct 29, 2014: KHB Announces 2014 Third Quarter Report
    • 14.2.15. Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014
  • 14.3. Government and Public Interest
    • 14.3.1. Oct 15, 2014: Mindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs
  • 14.4. Legal And Regulatory
    • 14.4.1. Dec 11, 2014: Shuwen Biotech Receives License to Operate New Diagnostic Reference Lab in China and Forms New Subsidiary for the Lab
  • 14.5. Other Significant Developments
    • 14.5.1. Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC
    • 14.5.2. Feb 12, 2015: Mindray Signs Contract with Kenyan Government to Facilitate National Healthcare Project
    • 14.5.3. Feb 06, 2015: Response Biomedical Announces Expansion of Chinese Distribution Agreement for RAMP Cardiovascular Products
    • 14.5.4. Dec 09, 2014: Fred Hutch, China partner to collect samples of all types of cancer
    • 14.5.5. Oct 20, 2014: Pressure BioSciences Announces Partnership with Powertech Technology Company Ltd. to Develop China Market for PBI's PCT Platform
  • 14.6. Product News
    • 14.6.1. Jul 27, 2015: CBMG Announces Successful New Certifications for Proprietary Cell and Tissue Preservation Media Kits
    • 14.6.2. Jul 09, 2015: BioNano Genomics Announces Addition of Gene Company as China Mainland and HK/Macau Distributor
  • 14.7. Strategy And Business Planning
    • 14.7.1. Sep 16, 2015: WuXi NextCODE and Fudan Children's Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China
    • 14.7.2. Sep 01, 2015: Agena Bioscience Opens Office in Shanghai, China
    • 14.7.3. Jun 23, 2015: SGS Life Science Services Completes New Laboratories At Its Shanghai Facility
    • 14.7.4. Jan 19, 2015: PerkinElmer Opens New Medical Laboratory in Suzhou, China
    • 14.7.5. Jan 09, 2015: Meridian Opens a New Office in Beijing, China
    • 14.7.6. Oct 30, 2014: Irvine Pharmaceutical Services Announces The Opening Of An Analytical Facility In Hangzhou, China
    • 14.7.7. Oct 30, 2014: Sartorius Opens New Application Center in Shanghai
    • 14.7.8. Oct 22, 2014: Gerresheimer Opens Its First Development Center In China

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Coverage
    • 15.1.2. Secondary Research
    • 15.1.3. Primary Research
    • 15.1.4. Company Share Analysis
    • 15.1.5. Distribution Share Analysis
  • 15.2. GlobalData Consulting
  • 15.3. Contact Us
  • 15.4. Disclaimer

List of Tables

  • Table 1: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, 2007-2021
  • Table 2: In Vitro Diagnostics Market, China, Category Contribution by Revenue ($m), 2014
  • Table 3: In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 4: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: In Vitro Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 7: Clinical Chemistry Market, China, Segment Contribution (%), 2014
  • Table 8: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Genetic Testing Market, China, Segment Contribution (%), 2014
  • Table 19: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 20: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 21: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 22: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 23: Haematology Market, China, Segment Contribution (%), 2014
  • Table 24: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 28: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 29: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 33: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 37: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 38: Histology And Cytology Market, China, Segment Contribution (%), 2014
  • Table 39: Histology And Cytology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Histology And Cytology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 41: Histology And Cytology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 42: Histology And Cytology Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 43: Immuno Chemistry Market, China, Segment Contribution (%), 2014
  • Table 44: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 45: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Anemia Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 47: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 48: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Vitamins Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Anemia Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 54: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Vitamins Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Immuno Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Immuno Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Infectious Diagnostics Market, China, Segment Contribution (%), 2014
  • Table 63: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 64: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 65: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 67: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Microbiology Culture Market, China, Segment Contribution (%), 2014
  • Table 70: Microbiology Culture Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 71: Microbiology Culture Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 73: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Microbiology Culture Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Microbiology Culture Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: In Vitro Diagnostics Market Pipeline Products
  • Table 77: Zhejiang Hisun Pharma to Acquire 33% Stake in Zhejiang-based Medical Apparatus and Instruments Company for USD2.3 Million
  • Table 78: Hangzhou Century to Acquire Ewell for USD178 Million
  • Table 79: Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million
  • Table 80: Beijing Leadman Biochemistry Plans to Acquire Stakes in Shanghai Units of DiaSys Diagnostic Systems for USD55.4 Million
  • Table 81: Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes
  • Table 82: Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares
  • Table 83: Lepu Medical Technology to Raise USD200.8 Million in Private Placement of Shares
  • Table 84: Guangzhou Wondfo Biotech Raises USD57.5 Million in IPO
  • Table 85: Lepu Medical Amends Terms of Private Placement of Shares for USD208 Million
  • Table 86: Beijing Strong Biotech Prices IPO for USD57 Million
  • Table 87: Beijing Leadman Biochemistry Plans to Raise USD18.5 Million in Private Placement
  • Table 88: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept
  • Table 89: Seegene Enters into Co-Development Agreement with BD Life Sciences
  • Table 90: OriGene Technologies Enters into Licensing Agreement with Diadexus
  • Table 91: MdxHealth Enters into Licensing Agreement with Erasmus MC
  • Table 92: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
  • Table 93: Sigma-Aldrich Enters into Distribution Agreement with LGC
  • Table 94: OvaGene Oncology Enters into Agreement with Etta Healthcare
  • Table 95: Shuwen Biotech Enters into Agreement with Jiangsu Hengrui Medicine
  • Table 96: InTouch Health Enters into Agreement with iSchemaView
  • Table 97: DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
  • Table 98: Shanghai Runda to Form Joint Venture with Sinopharm
  • Table 99: Illumina Enters into Co-Development Agreement with Annoroad Gene Technology
  • Table 100: WuXi AppTec Enters into Agreement with Fudan University
  • Table 101: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
  • Table 102: Livzon Pharma to Form Joint Venture with Cynvenio Biosystems
  • Table 103: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests
  • Table 104: Shanghai Lidebiotech Enters into Agreement with Clearbridge BioMedics
  • Table 105: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test
  • Table 106: IncellDx Enters into Licensing Agreement with Claremont BioSolutions
  • Table 107: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing
  • Table 108: AngioDynamics Enters into Licensing Agreement with EmboMedics
  • Table 109: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems
  • Table 110: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology
  • Table 111: Biocartis Enters into Licensing and Development Agreement with Microbiome
  • Table 112: CBScientific Enters into Distribution Agreement with UTest
  • Table 113: GeneThera Enters into Co-Development Agreement with Hudson Robotics
  • Table 114: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D
  • Table 115: Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
  • Table 116: Genomic Vision Extends Agreement with Quest Diagnostics
  • Table 117: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ
  • Table 118: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software
  • Table 119: BioMerieux Enters into Licensing Agreement with Astute Medical
  • Table 120: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology
  • Table 121: NoemaLife Enters into Distribution Agreement with Horiba Medical
  • Table 122: Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management
  • Table 123: Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
  • Table 124: Enigma Diagnostics Forms Joint Venture with Beijing Leadman Biochemistry
  • Table 125: Clinical Genomics Enters into Licensing Agreement with CSIRO
  • Table 126: Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical
  • Table 127: Mindray Medical Receives Revised Non-Binding Going Private Proposal from Li Xiting, Xu Hang and Cheng Minghe
  • Table 128: CANbridge Life Sciences Raises USD10 Million in Series A Venture Financing

List of Figures

  • Figure 1: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: In Vitro Diagnostics Market, China, Revenue Mix ($m), 2014
  • Figure 3: In Vitro Diagnostics Market, China, Category Contribution (%), 2014
  • Figure 4: In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 5: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: In Vitro Diagnostics Market, China, Company Share (%) 2014
  • Figure 8: Clinical Chemistry Market, China, Revenue Mix ($m), 2014
  • Figure 9: Clinical Chemistry Market, China, Segment Contribution (%), 2014
  • Figure 10: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 15: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Clinical Chemistry Market, China, Company Share (%) 2014
  • Figure 19: Genetic Testing Market, China, Revenue Mix ($m), 2014
  • Figure 20: Genetic Testing Market, China, Segment Contribution (%), 2014
  • Figure 21: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Genetic Testing Market, China, Company Share (%) 2014
  • Figure 24: Haematology Market, China, Revenue Mix ($m), 2014
  • Figure 25: Haematology Market, China, Segment Contribution (%), 2014
  • Figure 26: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 32: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 35: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 36: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 37: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 38: Haematology Market, China, Company Share (%) 2014
  • Figure 39: Histology And Cytology Market, China, Revenue Mix ($m), 2014
  • Figure 40: Histology And Cytology Market, China, Segment Contribution (%), 2014
  • Figure 41: Histology And Cytology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 42: Histology And Cytology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Histology And Cytology Market, China, Company Share (%) 2014
  • Figure 44: Immuno Chemistry Market, China, Revenue Mix ($m), 2014
  • Figure 45: Immuno Chemistry Market, China, Segment Contribution (%), 2014
  • Figure 46: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 48: Anemia Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 53: Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 54: Vitamins Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 55: Anemia Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 58: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 59: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Immunochemistry Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 61: Vitamins Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 62: Immuno Chemistry Market, China, Company Share (%) 2014
  • Figure 63: Infectious Diagnostics Market, China, Revenue Mix ($m), 2014
  • Figure 64: Infectious Diagnostics Market, China, Segment Contribution (%), 2014
  • Figure 65: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 66: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 68: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Infectious Diagnostics Market, China, Company Share (%) 2014
  • Figure 70: Microbiology Culture Market, China, Revenue Mix ($m), 2014
  • Figure 71: Microbiology Culture Market, China, Segment Contribution (%), 2014
  • Figure 72: Microbiology Culture Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 73: Microbiology Culture Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 74: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 75: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 76: Microbiology Culture Market, China, Company Share (%) 2014
Back to Top